JPMorgan upgraded James Hardie (JHX) to Overweight from Neutral with a price target of A$55, up from A$52, ahead of the Q2 report on November 13. While the firm sees risks to the top end of the company’s fiscal 2025 guidance, it believes consensus earnings remain “fairly conservative,” sitting at the lower end of the range. Peer commentary in recent results has skewed marginally positive, with modest improvements in housing activity anticipated in 2025, the analyst tells investors in a research note.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks